Cargando…

Selection of external beam radiotherapy approaches for precise and accurate cancer treatment

Physically precise external-beam radiotherapy (EBRT) technologies may not translate to the best outcome in individual patients. On the other hand, clinical considerations alone are often insufficient to guide the selection of a specific EBRT approach in patients. We examine the ways in which to comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirato, Hiroki, Le, Quynh-Thu, Kobashi, Keiji, Prayongrat, Anussara, Takao, Seishin, Shimizu, Shinichi, Giaccia, Amato, Xing, Lei, Umegaki, Kikuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Supplement Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868193/ https://www.ncbi.nlm.nih.gov/pubmed/29373709 http://dx.doi.org/10.1093/jrr/rrx092

Ejemplares similares

Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy
por: Kobashi, Keiji, et al.
Publicado: (2018)

Present developments in reaching an international consensus for a model-based approach to particle beam therapy
por: Prayongrat, Anussara, et al.
Publicado: (2018)

Dynamic gating window technique for the reduction of dosimetric error in respiratory‐gated spot‐scanning particle therapy: An initial phantom study using patient tumor trajectory data
por: Miyamoto, Naoki, et al.
Publicado: (2020)

A motion-compensated image filter for low-dose fluoroscopy in a real-time tumor-tracking radiotherapy system
por: Miyamoto, Naoki, et al.
Publicado: (2015)

Prediction of target position from multiple fiducial markers by partial least squares regression in real-time tumor-tracking radiation therapy
por: Ukon, Kanako, et al.
Publicado: (2021)

Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system
por: Nishioka, Kentaro, et al.
Publicado: (2018)

A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostate
por: Fujii, Yusuke, et al.
Publicado: (2017)

What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy
por: Toramatsu, Chie, et al.
Publicado: (2013)

Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients
por: Prayongrat, Anussara, et al.
Publicado: (2022)

Correction: Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients
por: Prayongrat, Anussara, et al.
Publicado: (2023)

Preface
por: Le, Quynh-Thu, et al.
Publicado: (2018)

Lysosomal trafficking mediated by Arl8b and BORC promotes invasion of cancer cells that survive radiation
por: Wu, Ping-Hsiu, et al.
Publicado: (2020)

Validation of dose distribution for liver tumors treated with real-time-image gated spot-scanning proton therapy by log data based dose reconstruction
por: Yamada, Takahiro, et al.
Publicado: (2021)

Difference in LET‐based biological doses between IMPT optimization techniques: Robust and PTV‐based optimizations
por: Hirayama, Shusuke, et al.
Publicado: (2020)

Lambda-Carrageenan Enhances the Effects of Radiation Therapy in Cancer Treatment by Suppressing Cancer Cell Invasion and Metastasis through Racgap1 Inhibition
por: Wu, Ping-Hsiu, et al.
Publicado: (2019)

Assessment of the confidence interval in the multivariable normal tissue complication probability model for predicting radiation-induced liver disease in primary liver cancer
por: Prayongrat, Anussara, et al.
Publicado: (2021)

Rab27b contributes to radioresistance and exerts a paracrine effect via epiregulin in glioblastoma
por: Nishioka, Soichiro, et al.
Publicado: (2020)

A Proton Beam Therapy System Dedicated to Spot-Scanning Increases Accuracy with Moving Tumors by Real-Time Imaging and Gating and Reduces Equipment Size
por: Shimizu, Shinichi, et al.
Publicado: (2014)

Analysis of treatment process time for real‐time‐image gated‐spot‐scanning proton‐beam therapy (RGPT) system
por: Yoshimura, Takaaki, et al.
Publicado: (2019)

Quantitative analysis of treatments using real‐time image gated spot‐scanning with synchrotron‐based proton beam therapy system log data
por: Yoshimura, Takaaki, et al.
Publicado: (2020)

Radiomics and radiogenomics for precision radiotherapy
por: Wu, Jia, et al.
Publicado: (2018)

Physical and biological impacts of collimator‐scattered protons in spot‐scanning proton therapy
por: Ueno, Koki, et al.
Publicado: (2019)

Digital fabrication of customized intraoral appliances for head and neck radiotherapy
por: Prayongrat, Anussara, et al.
Publicado: (2023)

A Literature Review of Proton Beam Therapy for Prostate Cancer in Japan
por: Hoshina, Rika Maglente, et al.
Publicado: (2019)

Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
por: Wu, Ping-Hsiu, et al.
Publicado: (2017)

Simultaneous Tc-99m and I-123 dual-radionuclide imaging with a solid-state detector-based brain-SPECT system and energy-based scatter correction
por: Takeuchi, Wataru, et al.
Publicado: (2016)

Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients
por: Yasuda, Koichi, et al.
Publicado: (2020)

Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience
por: Prayongrat, Anussara, et al.
Publicado: (2017)

Potential benefits of adaptive intensity‐modulated proton therapy in nasopharyngeal carcinomas
por: Minatogawa, Hideki, et al.
Publicado: (2020)

A novel range-verification method using ionoacoustic wave generated from spherical gold markers for particle-beam therapy: a simulation study
por: Takayanagi, Taisuke, et al.
Publicado: (2019)

A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer
por: Yoshimura, Takaaki, et al.
Publicado: (2021)

Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients
por: Prayongrat, Anussara, et al.
Publicado: (2023)

Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
por: Prayongrat, Anussara, et al.
Publicado: (2017)

Comparison of the average surviving fraction model with the integral biologically effective dose model for an optimal irradiation scheme
por: Takagi, Ryo, et al.
Publicado: (2018)

Real-Time Tumor-Tracking Radiotherapy and General Stereotactic Body Radiotherapy for Adrenal Metastasis in Patients With Oligometastasis
por: Katoh, Norio, et al.
Publicado: (2018)

Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults
por: Hashimoto, Takayuki, et al.
Publicado: (2019)

A Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-β-D-Ribo-Pentofuranosyl)Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton Beam
por: Maeda, Kenichiro, et al.
Publicado: (2016)

Prognostic Value of Plasma EBV DNA for Nasopharyngeal Cancer Patients during Treatment with Intensity-modulated Radiation Therapy and Concurrent Chemotherapy
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2018)

Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2018)

High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma
por: Lertbutsayanukul, Chawalit, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_js56ouoav6lm6nrmd46kd00970